Targeted mutations of breast cancer susceptibility gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

Genes and Development

Volumn 11, Issue 10, 1997, Pages 1226-1241

  Ludwig, Thomas ^a   Chapman, Deborah L ^a   Papaioannou, Virginia E ^a   Efstratiadis, Argiris ^a  

^a Columbia University ^*  (United States)

Author keywords

Brca1; Brca2; embryonic lethality; mouse mutant; p53

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLASTOCYST; BREAST CANCER; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; EMBRYO DEVELOPMENT; GENE DISRUPTION; GENE TARGETING; GENETIC CODE; GENETIC ORGANIZATION; GENETIC SUSCEPTIBILITY; MARKER GENE; MOUSE; NONHUMAN; NULL CELL; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ZYGOTE;

EID: 0030924656     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.10.1226     Document Type: Article

References (102)

1. Abel, K.J., J. Xu, G.-Y. Yin, R.H. Lyons, M.H. Meisler, and B.L. Weber. 1995. Mouse Brca 1: Isolation, sequence analysis and identification of evolutionary conserved domains. Hum. Mol. Genet. 12: 2265-2273.
2. Armstrong, J.F., M.H. Kaufman, D.J. Harrison, and A.R. Clarke. 1995. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5: 931-936.
3. Avery, L. and S. Wasserman. 1992. Ordering gene function, the interpretation of epistasis in regulatory hierarchies. Trends Genet. 8: 312-316.
4. Bates, S. and K.H. Vousden. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6: 12-19.
5. Bennett, M.L., A. Haugen-Strano, C. Cochran, H.A. Brownlee, F.T. Fiedorek, and R.W. Wiseman. 1995. Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. Genomics 29: 576-581.
6. Bingell, G., G. Micklem, M.R. Stratton, A. Ashworth, and R. Wooster. 1997. The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet. 6: 53-58.
7. Bishop, C.E. and D. Hatat. 1987. Molecular cloning and sequence analysis of a mouse Y chromosome RNA transcript expressed in the testis. Nucleic Acids Res. 15: 2959-2969.
8. Bork, P., N. Blomberg, and M. Nigles. 1996. Internal repeats in the BRCA2 protein sequence. Nature Genet. 13: 22-23.
9. Bork, P., K. Hofmann, P. Bucher, A.F. Neuwald, S.F. Altschul, and E.V. Koonin. 1997. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11: 68-76.
10. Boyd, M., F. Harris, R. McFarlane, H.R. Davidson, and D.M. Black. 1995. A human BRCA1 gene knockout. Nature 375: 541-542.
11. Brown, M.A., C.-F. Xu, H. Nicolai, B. Griffiths, J.A. Chambers, D. Black, and E. Solomon. 1996. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogens 12: 2507-2513.
12. Callebaut, I. and J.-P. Mornon. 1997. From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair. FEBS Lett. 400: 25-30.
13. Cannon-Albright, L.A. and M.H. Skolnick. 1996. The genetics of familial breast cancer. Semin. Oncol. 23(Suppl. 2): 1-5.
14. Carr, A.M. and M.F. Hoekstra. 1995. The cellular responses to DNA damage. Trends Cell Biol. 5: 32-40.
15. Chapman, M.S. and I.M. Verma. 1996. Transcriptional activation by BRCA1. Nature 382: 678-679.
16. Chen, C.-F., S. Li, Y. Chen, P.-L. Chen, Z.D. Sharp, and W.-H. Lee. 1996. The nuclear localization sequences of the BRCA1 protein interact with the importin-a subunit of the nulcear transport signal receptor. J. Biol. Chem. 271: 32863-32868.
17. Chen, Y., A.A. Farmer, C.-F. Chen, D.C. Jones, P.-L. Chen, and W.-H. Lee. 1996. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56: 3168-3172.
18. Claus, E.B., N. Risch, and W.D. Thompson. 1991. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48: 232-242.
19. Collins, N., R. McManus, R. Wooster, J. Mangion, S. Seal, S.R. Lakhani, W. Ormiston, P.A. Daly, D. Ford, D.F. Easton, et al. 1995. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10: 1673-1675.
20. Connor, F., A. Smith, R. Wooster, M. Stratton, A. Dixon, E. Campbell, T.-C. Tait, T. Freeman, and A. Ashworth. 1997. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum. Mol. Genet. 6: 291-300.
21. Copp, A.J. 1995. Death before birth: Clues from gene knockouts and mutations. Trends Genet. 11: 87-93.
22. Couch, F.J., L.M. Farid, M.L. DeShano, S.V. Tavtigian, K. Calzone, L. Campeau, Y. Peng, B. Bogden, Q. Chen, S. Neuhausen, et al. 1996. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet. 13: 123-125.
23. DeBry, R.W. and M.F. Seldin. 1996. Human/mouse homology relationships. Genomics 33: 337-351.
24. Dunn, G.R. 1972. Embryological effects of a minute deficiency in linkage group II of the mouse. J. Embryol. Exp. Morphol. 27: 147-154.
25. Easton, D.F., D. Ford, and J. Peto. 1993. Inherited susceptibility to breast cancer. Cancer Surv. 18: 95-113.
26. Easton, D.F., D. Ford, D.T. Bishop, and the Breast Cancer Linkage Consortium. 1995. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet. 56: 265-271.
27. Eisinger, F., D. Stoppa-Lyonnet, M. Longy, F. Kerangueven, T. Noguchi, C. Bailly, A. Vincent-Salomon, J. Jacquemier, D. Birnbaum, and H. Sobol. 1996. Germ line mutation of BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res. 56: 471-474.
28. Feunteun, J. and G.M. Lenoir. 1996. BRCA1, a gene involved in inherited predisposition to breast and ovarian cancer. Biochim. Biophys. Acta 1242: 177-180.
29. Fischer, S.G., E. Cayanis, M. Bonaldo, A.M. Bowcock, L.L. Deaven, I.S. Edelman, T. Gallardo, S. Kalachikov, L. Lawton, J.L. Longmire, et al. 1996. A high-resolution annotated physical map of the human chromosome 13q12-13 region containing the breast cancer susceptibility locus BRCA2. Proc. Natl. Acad. Sci. 93: 690-694.
30. Freemont, P.S. 1993. The RING finger, a novel protein sequence motif related to the zinc finger. Ann. N.Y. Acad. Sci. 684: 174-192.
31. Gayther, S.A., W. Warren, S. Mazoyer, P.A. Russell, P.A. Harrington, M. Chiano, S. Seal, R. Hamoudi, E.J. van Rensburg, A.M. Dunning et al. 1995. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet. 11: 428-433.
32. Godley, L.A., J.B. Kopp, M. Eckhaus, J.J. Paglino, J. Owens, and H.E. Varmus. 1996. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes & Dev. 10: 836-850.
33. Goggins, M., M. Schutte, J.L. Lu, C.A. Moskaluk, C.L. Weinstein, G.M. Petersen, C.J. Yeo, C.E. Jackson, H.T. Lynch, R.H. Hruban, and S.E. Kern. 1996. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56: 5360-5364.
34. Gottlieb, T.M. and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287: 77-102.
35. Gowen, L.C., B.L. Johnson, A.M. Latour, K.K. Sulik, and B.H. Koller. 1996. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nature Genet. 12: 191-194.
36. Gudas, J.M., T. Li, H. Nguyen, D. Jensen, F.J. Rauscher, and K.H. Cowan. 1996. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7: 717-723.
37. Hakem, R., J.L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C.C. Hui, J. Roberts, J. Rossant, and T.W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023.
38. Hansen, R. and M. Oren. 1997. p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7: 46-51.
39. Hayashi, Y., M. Koike, M. Matsutani, and T. Hoshino. 1988. Effects of fixation time and enzymatic digestion on immunohistochemical demonstration of bromodeoxyundine in formalin-fixed, paraffin-embedded tissues. J. Histochem. Cytochem. 36: 511-514.
40. Wis mutant embryos. Development 113: 913-917.
41. Holt, J.T., M.E. Thompson, C.I. Szabo, C. Robinson-Benion, C.L. Arteaga, M.-C. King, and R.A. Jensen. 1996. Growth retardation and tumour inhibition by BRCA1. Nature Genet. 12: 298-302.
42. Imai, K. and D.M. Kingsley. 1994. Mouse chromosome 9. Mamm. Genome 5: S139-S153.
43. Iwabuchi, K., P.L. Bartel, B. Li, R. Marraccino, and S. Fields. 1994. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. 91: 6098-6102.
44. Jacks, T., T.S. Shih, E.M. Schmitt, R.D. Bronson, A. Bernards, and R.A. Weinberg. 1994a. Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nature Genet. 7: 353-361.
45. Jacks, T., L. Remington, B.O. Williams, E.M. Schmitt, S. Halachmi, R.T. Bronson, and R.A. Weinberg. 1994b. Tumor spectrum analysis in p.53-mutant mice. Curr. Biol. 4: 1-7.
46. Johannsson, O., E.A. Ostermeyer, S. Håkansson, L.S. Friedman, U. Johansson, G. Sellberg, K. Brøndum-Nielsen, V. Sele, H. Olsson, M.-C. King, and Å. Borg. 1996. Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am. J. Hum. Genet. 58: 441-450.
47. Jones, S.N., A.E. Roe, L.A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
48. Kelsell, D.P., N.K. Spurr, D.M. Barnes, B. Gusterson, and D.T. Bishop. 1996. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347: 1554-1555.
49. Kingsley, D.M., A.E. Bland, J.M. Grubber, P.C. Marker, L.B. Russell, N.G. Copeland, and N.A. Jenkins. 1992. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily. Cell 71: 399-410.
50. Koonin, E.V., S.F. Altschul, and P. Bork. 1996. [BRCA1 protein products], functional motifs. Nature Genet. 13: 266-268.
51. Kreidberg, J.A., H. Sariola, J.M. Loring, M. Maeda, f. Pelletier, D. Housman, and R. Jaenisch. 1993. WT-1 is required for early kidney development. Cell 74: 679-691.
52. Lancaster, J.M., R. Wooster, J. Mangion, C.M. Phelan, C. Cochran, C. Gumbs, S. Seal, R. Barfoot, N. Collins, G. Bingell, et al. 1996. BRCA2 mutations in primary breast and ovarian cancers. Nature Genet. 13: 238-240.
53. Lane, T.F., C. Deng, A. Elson, M.S. Lyu, C.A. Kozak, and P. Leder. 1995. Expression of Brca 1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes & Dev. 9: 2712-2722.
54. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
55. Lim, D.-S. and P. Hasty. 1996. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53, Mol. Cell. Biol. 16: 7133-7143.
56. Liu, C.-Y., A. Flesken-Nikitin, S. Li, Y. Zeng, and W.-H. Lee. 1996. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes & Dev. 10: 1835-1843.
57. Maldonado, E., R. Shiekhattar, M. Sheldon, H. Cho, R. Drapkin, P. Rickert, E. Lees, C.W. Anderson, S. Linn, and D. Reinberg. 1996. A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature 381: 86-89.
58. Marcus, J.N., P. Watson, D.L. Page, S.A. Narod, G.M. Lenoir, P. Tonin, L. Linder-Stephenson, G. Salerno, T.A. Conway, and H.T. Lynch. 1996. Hereditary breast cancer, pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77: 697-709.
59. Miki, Y., J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71.
60. Miki, Y., T. Katagiri, F. Kasumi, T. Yoshimoto, and Y. Nakamura. 1996. Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet. 13: 245-247.
61. Mishina, Y., A. Suzuki, N. Ueno, and R.R. Behringer. 1995. Bmpr encodes a type 1 bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes & Dev. 9: 3027-3037.
62. Monteiro, A.N.A., A. August, and H. Hanafusa. 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. 93: 13595-13599.
63. Montes de Oca Luna, R., D.S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
64. Neuhausen, S.L. and C.J. Marshall. 1994. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 54: 6069-6072.
65. Neuhausen, S., T. Gilewski, L. Norton, T. Tran, P. McGuire, J. Swensen, H. Hampel, P. Borgen, K. Brown, M. Skolnick, et al. 1996. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet. 13: 126-128.
66. Orphanos, V., G. McGown, J.M. Boyle, and M. Santibanez-Koref. 1995. Proximal 6q, a region showing allele loss in primary breast cancer. Br. J. Cancer 71: 290-293.
67. Phelan, C.M., J.M. Lancaster, P. Tonin, C. Gumbs, C. Cochran, R. Carter, P. Ghadirian, C. Perret, R. Moslehi, F. Dion, et al. 1996. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet. 13: 120-122.
68. Rajan, J.V., M. Wang, S.T. Marquis, and L.A. Ghodosh. 1996. Brca2 is coordinately regulated with Brcal during proliferation and differentiation in mammary epithelial cells. Proc. Natl Acad. Sci. 93: 13078-13083.
69. Ramus, S.J., L.S. Friedman, S.A. Gayther, B.A. Ponder, L.G. Bobrow, M. van der Looji, J. Papp, and E. Olah. 1997. A breast/ ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Nature Genet. 15: 14-15.
70. Rao, V.N., N. Shao, M. Ahmad, and E.S.P. Reddy. 1996. Antisense RNA to a putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12: 523-528.
71. Russell, L.B. 1971. Definition of functional units in a small chromosomal segment of the mouse and its use in interpreting the nature of radiation-induced mutations. Mutat. Res. 11: 107-123.
72. Sah, V.P., L.D. Attardi, G.J. Mulligan, B.O. Williams, R.T. Bronson, and T. Jacks. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10: 175-180.
73. Saurin, A.J., K.L.B. Borden, M.N. Boddy, and P.S. Freemont. 1996. Does this have a familiar RING? Trends Biochem. Sci. 21: 208-214.
74. Schöler, H.R., G.R. Dressler, R. Balling, H. Rohdewohld, and P. Gruss. 1990. Oct-4, a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9: 2185-2195.
75. Schutte, M., L.T. DaCosta, S.A. Hahn, C. Moskaluk, A.T.M.S. Hoque, E. Rozenblum, C.L. Weinstein, M. Bittner, P.S. Meltzer, J.M. Trent, et al. 1995. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. 92: 5950-5954.
76. Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D.M. Livingston. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275.
77. Serova, O., M. Montagna, D. Torchard, S.A. Narod, P. Tonin, B. Sylla, H.T. Lynch, J. Feunteun, and G.M. Lenoir. 1996. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J. Hum. Genet. 58: 42-51.
78. Sharan, S.K. and A. Bradley. 1997. Murine Brca2: Sequence, map position, and expression pattern. Genomics 40: 234-241.
79. Sharan, S.K., M. Wims, and A. Bradley. 1995. Murine Brca1, sequence and significance for human missense mutations. Hum. Mol Genet. 12: 2275-2278.
80. Smith, S.A., D.F. Easton, D.G. Evans, and B.A. Ponder. 1992. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet. 2: 128-131.
81. Smith, T.M., M.K. Lee, C.I. Szabo, N. Jerome, M. McEuen, M. Taylor, L. Hood, and M.-C. King. 1996. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res. 6: 1029-1049.
82. Snow, M.H.L. 1977. Gastrulation in the mouse: Growth and regionalization of the epiblast. J. Embryol. Exp. Morphol. 42: 293-303.
83. Spillman, M.A. and A.M. Bowcock. 1996. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to es trogen. Oncogene 13: 1639-1645.
84. Stratton, M.R. and R. Wooster. 1996. Hereditary predisposition to breast cancer. Curr. Opin. Genet. Dev. 6: 93-97.
85. Stürzbecher, H.-W., B. Donzelmann, W. Henning, U. Knippschild, and S. Buchhop. 1996. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15: 1992-2002.
86. Szabo, C.I. and M.-C. King. 1995. Inherited breast and ovarian cancer. Hum. Mol. Genet. 4: 1811-1817.
87. Tavtigian, S.V., J. Simard, J. Rommens, F. Couch, D. Shattuck-Eidens, S. Neuhausen, S. Marajver, S. Thorlacius, K. Offit, D. Stoppa-Lyonnet, et al. 1996. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet. 12: 333-337.
88. Teng, D.H.-F., R. Bogden, J. Mitchell, M. Baumgard, R. Bell, S. Berry, T. Davis, P.C. Ha, R. Kehrer, S. Jammulapati, et al. 1996. Low incidence of BRCA2 mutations in breast carcinoma and other cancer. Nature Genet. 13: 241-244.
89. Thakur, S., H.B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L.M. Farid, F.J. Couch, R.B. Wilson, and B.L. Weber. 1997. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17: 444-452.
90. Thompson, M.E., R.A. Jensen, P.S. Obermiller, D.L. Page, and J.T. Holt. 1995. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9: 444-450.
91. Thorlacius, S., G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J.G. Jonasson, S. Tavtigian, H Tulinius, H.M. Ögmunsdottir, and J.E. Eyfjörd. 1996. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet. 13: 117-119.
92. Vaughn, J.P., P.L. Davis, M.D. Jarboe, G. Huper, A.C. Evans, R.W. Wiseman, A. Berchuck, J.D. Iglehart, P.A. Futreal, and J.R. Marks. 1996a. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7: 711-715.
93. Vaughn, J.P., F.D. Cirisano, G. Huper, A. Berchuck, P.A. Futreal, J.R. Marks, and J.D. Iglehart. 1996b. Cell cycle control of BRCA2. Cancer Res. 56: 4590-4594.
94. Wilkinson, D.G. 1992. Whole-mount in situ hybridization of vertebrate embryos. In In situ hybridization: A practical approach (ed. D.G. Wilkinson), pp. 75-83. IRL Press, Oxford, UK.
95. Wilkinson, D.G., S. Bhatt, and B.G. Herrmann. 1990. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 343: 657-659.
96. Wilson, C.A., M.N. Payton, G.S. Elliot, F.W. Buaas, E.E. Cajulis, D. Grosshans, L. Ramos, D.M. Reese, D.J. Slamon, and F.J. Calzone. 1997. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b. Oncogene 14: 1-16.
97. Wooster, R., G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, et al. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792.
98. Wu, L.C., Z.W. Wang, J.T. Tsan, M.A. Spillman, A. Phung, X.L. Xu, M.-C.W. Yang, L.-Y. Hwang, A.M. Bowcock, and R. Baer. 1996. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nature Genet. 14: 430-440.
99. Xu, C.-F., M.A. Brown, J.A. Chambers, B. Griffiths, H. Nicolai, and E. Solomon. 1995. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Genet. 4: 2259-2264.
100. Xu, C.-f. and E. Solomon. 1996. Mutations of the BRCA1 gene in human cancer. Cancer Biol. 7: 33-40.
101. Yeom, Y., G. Fuhrmann, C.E. Ovitt, A. Brehm, K. Ohbo, M. Gross, K. Hübner, and H.R. Schöler. 1996. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122: 881-894.
102. Zeitlin, S., J.-P. Liu, D.L. Chapman, V.E. Papaioannou, and A. Efstratiadis. 1995. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homolog. Nature Genet. 11: 155-163.